Michael R. Lassen - Concepedia

Author

Michael R. Lassen

Also Known As

Bengt Eriksson, Lassen, M.R., M Lassen, M R Lassen, M Rud Lassen, M. Lassen, M. R. LASSEN, M. R. Lassen, M.R Lassen, M.R. LASSEN

198

Publications

22.6K

Citations

H-Index

Concepts

All Affiliations

University of Copenhagen Sahlgrenska University Hospital Aalborg University Hospital Glostrup Hospital McMaster University

About

Michael R. Lassen is an author at University of Copenhagen specializing in medicine, thrombosis, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	51	5.3K
2	Public Health	7	7	572
3	Health Sciences	4	4	189
4	Management	1	1	11
5	Anesthesia	1	1	45

Michael R. Lassen

Publications

12.3K

Citations

H-Index

Page 1

	Year	Citations
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty Michael R. Lassen, Walter Ageno, Lars C. Borris, New England Journal of Medicine	2008	1.3K
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial Alexander GG Turpie, Michael R. Lassen, Bruce L. Davidson, The Lancet ThrombosisRivaroxaban Versus EnoxaparinVenous ThrombosisRandomised TrialOrthopaedics	2009	978
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial Alexander T Cohen, Bruce L. Davidson, Alexander Gallus, BMJ	2006	852
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial Michael R. Lassen, Gary E. Raskob, Alexander Gallus, The Lancet ThrombosisClinical TrialsKnee ReplacementOrthopaedicsApixaban Versus Enoxaparin	2010	775
Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement Michael R. Lassen, Alexander Gallus, Gary E. Raskob, New England Journal of Medicine	2010	769
Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement Michael R. Lassen, Gary E. Raskob, Alexander Gallus, New England Journal of Medicine	2009	692
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery Kenneth A. Bauer, Bengt I. Eriksson, Michael R. Lassen, New England Journal of Medicine	2001	633
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery Bengt I. Eriksson, Kenneth A. Bauer, Michael R. Lassen, New England Journal of Medicine	2001	631
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial Alexander GG Turpie, Kenneth A. Bauer, Bengt I. Eriksson, The Lancet ThrombosisVenous ThrombosisVascular SurgeryOutcomes ResearchElective Hip-replacement Surgery	2002	533
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer Giancarlo Agnelli, Daniel J. George, Ajay K. Kakkar, New England Journal of Medicine	2012	525

Page 1